<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39453913</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Arterial floating mural thrombi are a characteristic imaging pattern in SARS-CoV-2-related ischemic stroke.</ArticleTitle><Pagination><StartPage>e0311622</StartPage><MedlinePgn>e0311622</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0311622</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0311622</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute ischemic stroke (AIS) is a complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We aimed to explore neurovascular imaging patterns in patients with SARS-CoV-2-related AIS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively analyzed clinical and radiological data of patients hospitalized with AIS and a positive PCR test for SARS-CoV-2 prior to AIS onset. The control group comprised of AIS patients from a pre-COVID-19 pandemic period matched for gender and age.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-five SARS-CoV-2-related stroke patients, and 35 controls were included. Fifty-seven percent of SARS-CoV-2 patients had either mild or asymptomatic disease. A distinctive imaging pattern of floating arterial mural thrombus was detected in 5 patients of the SARS-CoV-2 group. In 4 patients thrombus was attached to a stenotic atherosclerotic plaque in the proximal internal carotid artery. In the 5th patient a cardiac CTA showed multiple floating thrombi in the descending aorta. In the control group, floating thrombus was only detected in one patient. Treatment with dual antiplatelet therapy was associated with thrombus dissolution and good clinical outcome. Patients with floating thrombi had a longer time from SARS-CoV-2 diagnosis to stroke onset (mean 7.4 versus 3.4 days).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Floating arterial mural thrombi attached to atherosclerotic plaques are unique characteristic source of AIS in SARS-CoV-2 patients. They may lead to ischemic stroke in patients with mild or asymptomatic infection up to 1-2 weeks from SARS-CoV-2 diagnosis. Patients with embolic AIS and SARS-CoV-2 diagnosis should perform high resolution cranio-cervical vascular imaging to evaluate floating thrombi as a potential embolic source.</AbstractText><CopyrightInformation>Copyright: © 2024 Pardo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pardo</LastName><ForeName>Keshet</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-5056-2368</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harnof</LastName><ForeName>Omer</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnea</LastName><ForeName>Rani</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naftali</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenan</LastName><ForeName>Gilad</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Shamir Medical Center, Be'er Ya'akov, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Auriel</LastName><ForeName>Eithan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peretz</LastName><ForeName>Shlomi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Shamir Medical Center, Be'er Ya'akov, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="Y">Ischemic Stroke</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>22</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>22</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39453913</ArticleId><ArticleId IdType="pmc">PMC11508162</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0311622</ArticleId><ArticleId IdType="pii">PONE-D-24-16018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen N. et al.. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507–513 (2020). doi: 10.1016/S0140-6736(20)30211-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilaloglu S. et al.. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System. JAMA 324, 799–801 (2020). doi: 10.1001/jama.2020.13372</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13372</ArticleId><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q., Tong X., George M. G., Chang A. &amp; Merritt R. K. COVID-19 and risk of acute ischemic stroke among Medicare beneficiaries aged 65 years or older: self-controlled case series study. Neurology 98, e778–e789 (2022). doi: 10.1212/WNL.0000000000013184</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000013184</ArticleId><ArticleId IdType="pmc">PMC8935393</ArticleId><ArticleId IdType="pubmed">35115387</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahjouei, S. et al. SARS-CoV-2 and Stroke Characteristics: A Report from the Multinational COVID-19 Stroke Study Group (preprint). (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8078130</ArticleId><ArticleId IdType="pubmed">33878892</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacopetta D. et al.. COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies. Viruses vol. 14 at doi: 10.3390/v14030573 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030573</ArticleId><ArticleId IdType="pmc">PMC8950852</ArticleId><ArticleId IdType="pubmed">35336980</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization, W. H. Laboratory Testing for Coronavirus Disease 2019 (COVID-19) in Suspected Human Cases: Interim Guidance, 2 March 2020. (2020).</Citation></Reference><Reference><Citation>Adams H. P. et al.. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24, 35–41 (1993). doi: 10.1161/01.str.24.1.35</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.str.24.1.35</ArticleId><ArticleId IdType="pubmed">7678184</ArticleId></ArticleIdList></Reference><Reference><Citation>Pau A. K. et al.. National Institutes of Health COVID-19 Treatment Guidelines Panel. Convalescent plasma for the treatment of COVID-19: perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel. Ann Intern Med 174, 93–95 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556653</ArticleId><ArticleId IdType="pubmed">32976026</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno A. et al.. Simplified modified rankin scale questionnaire: reproducibility over the telephone and validation with quality of life. Stroke 42, 2276–2279 (2011). doi: 10.1161/STROKEAHA.111.613273</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.111.613273</ArticleId><ArticleId IdType="pubmed">21680905</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L. et al.. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77, 683–690 (2020). doi: 10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbonde A. A. et al.. Stroke Features, Risk Factors, and Pathophysiology in SARS-CoV-2-Infected Patients. Mayo Clin. proceedings. Innov. Qual. outcomes 6, 156–165 (2022). doi: 10.1016/j.mayocpiqo.2022.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2022.01.003</ArticleId><ArticleId IdType="pmc">PMC8776423</ArticleId><ArticleId IdType="pubmed">35079695</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahjouei S. et al.. Risk of stroke in hospitalized SARS-CoV-2 infected patients: a multinational study. EBioMedicine 59, (2020). doi: 10.1016/j.ebiom.2020.102939</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102939</ArticleId><ArticleId IdType="pmc">PMC7429203</ArticleId><ArticleId IdType="pubmed">32818804</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi A. I. et al.. Acute ischemic stroke and COVID-19: an analysis of 27 676 patients. Stroke 52, 905–912 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903982</ArticleId><ArticleId IdType="pubmed">33535779</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkler A. E. et al.. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol. 77, 1366–1372 (2020). doi: 10.1001/jamaneurol.2020.2730</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2730</ArticleId><ArticleId IdType="pmc">PMC7333175</ArticleId><ArticleId IdType="pubmed">32614385</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackman N., Antoniak S., Wolberg A. S., Kasthuri R. &amp; Key N. S. Coagulation abnormalities and thrombosis in patients infected with SARS-CoV-2 and other pandemic viruses. Arterioscler. Thromb. Vasc. Biol. 40, 2033–2044 (2020). doi: 10.1161/ATVBAHA.120.314514</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.314514</ArticleId><ArticleId IdType="pmc">PMC7447001</ArticleId><ArticleId IdType="pubmed">32657623</ArticleId></ArticleIdList></Reference><Reference><Citation>Avila J., Long B., Holladay D. &amp; Gottlieb M. Thrombotic complications of COVID-19. Am. J. Emerg. Med. 39, 213–218 (2021). doi: 10.1016/j.ajem.2020.09.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.09.065</ArticleId><ArticleId IdType="pmc">PMC7528743</ArticleId><ArticleId IdType="pubmed">33036855</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E. et al.. Hematological findings and complications of COVID-19. Am. J. Hematol. 95, 834–847 (2020). doi: 10.1002/ajh.25829</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25829</ArticleId><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabatabai A. et al.. Factor VIII and functional protein C activity in critically ill patients with coronavirus disease 2019: a case series. A&amp;a Pract. 14, e01236 (2020). doi: 10.1213/XAA.0000000000001236</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/XAA.0000000000001236</ArticleId><ArticleId IdType="pmc">PMC7242090</ArticleId><ArticleId IdType="pubmed">32539272</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H. et al.. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin. Chem. Lab. Med. 58, 1116–1120 (2020). doi: 10.1515/cclm-2020-0188</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0188</ArticleId><ArticleId IdType="pubmed">32172226</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigada M. et al.. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J. Thromb. Haemost. 18, 1738–1742 (2020). doi: 10.1111/jth.14850</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14850</ArticleId><ArticleId IdType="pmc">PMC9906150</ArticleId><ArticleId IdType="pubmed">32302438</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. et al.. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N. Engl. J. Med. 382, e38 (2020). doi: 10.1056/NEJMc2007575</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2007575</ArticleId><ArticleId IdType="pmc">PMC7161262</ArticleId><ArticleId IdType="pubmed">32268022</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohmasi, S. et al. Management of acute aortoiliac arterial thrombosis in patients with the novel coronavirus disease 2019: A case series and systematic review of the literature. Ann. Vasc. Surgery-br. Reports Innov. 100105 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9259024</ArticleId><ArticleId IdType="pubmed">35821740</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders I., Stather P., Sivagangan P. &amp; Al-Jundi W. The Mysterious Risk of Arterial Thrombosis With COVID-19: A Case Series and Systematic Review of Acute Limb Ischaemia. Cureus 14, (2022). doi: 10.7759/cureus.25080</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.25080</ArticleId><ArticleId IdType="pmc">PMC9203266</ArticleId><ArticleId IdType="pubmed">35719753</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheruiyot I. et al.. Arterial thrombosis in coronavirus disease 2019 patients: a rapid systematic review. Ann. Vasc. Surg. 70, 273–281 (2021). doi: 10.1016/j.avsg.2020.08.087</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2020.08.087</ArticleId><ArticleId IdType="pmc">PMC7453204</ArticleId><ArticleId IdType="pubmed">32866574</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer-Perez S. et al.. Symptomatic common carotid free-floating thrombus in a COVID-19 patient, case report and literature review. Ann. Vasc. Surg. 73, 122–e1 (2021). doi: 10.1016/j.avsg.2021.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2021.02.008</ArticleId><ArticleId IdType="pmc">PMC7955774</ArticleId><ArticleId IdType="pubmed">33689754</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y. et al.. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc. Neurol. svn-2020 (2020). doi: 10.1136/svn-2020-000431</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/svn-2020-000431</ArticleId><ArticleId IdType="pmc">PMC7371480</ArticleId><ArticleId IdType="pubmed">32616524</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan S. et al.. Neurological manifestations in critically ill patients with COVID-19: a retrospective study. Front. Neurol. 11, 806 (2020). doi: 10.3389/fneur.2020.00806</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00806</ArticleId><ArticleId IdType="pmc">PMC7365850</ArticleId><ArticleId IdType="pubmed">32754114</ArticleId></ArticleIdList></Reference><Reference><Citation>Oba S. et al.. Arterial and venous thrombosis complicated in COVID-19: a retrospective single center analysis in Japan. Front. Cardiovasc. Med. 8, 767074 (2021). doi: 10.3389/fcvm.2021.767074</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.767074</ArticleId><ArticleId IdType="pmc">PMC8639692</ArticleId><ArticleId IdType="pubmed">34869681</ArticleId></ArticleIdList></Reference><Reference><Citation>Niang I., Thioub D. &amp; Ly M. Several cases of arterial thrombosis of the limbs revealing asymptomatic and paucisymptomatic COVID-19 infection. Pan Afr. Med. J. 38, (2021). doi: 10.11604/pamj.2021.38.209.28188</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2021.38.209.28188</ArticleId><ArticleId IdType="pmc">PMC8106787</ArticleId><ArticleId IdType="pubmed">33995815</ArticleId></ArticleIdList></Reference><Reference><Citation>Vo T. D. et al.. COVID-19–related Peripheral Arterial Thrombosis Treated in a Large Health Maintenance Organization. Ann. Vasc. Surg. 84, 6–11 (2022). doi: 10.1016/j.avsg.2022.04.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2022.04.024</ArticleId><ArticleId IdType="pmc">PMC9033289</ArticleId><ArticleId IdType="pubmed">35470048</ArticleId></ArticleIdList></Reference><Reference><Citation>Osilli D. et al.. mild COVID-19 infection and acute arterial thrombosis. J. Surg. Case Reports 2020, rjaa343 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7526473</ArticleId><ArticleId IdType="pubmed">33024534</ArticleId></ArticleIdList></Reference><Reference><Citation>Fara M. G. et al.. Macrothrombosis and stroke in patients with mild Covid-19 infection. J. Thromb. Haemost. 18, 2031–2033 (2020). doi: 10.1111/jth.14938</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14938</ArticleId><ArticleId IdType="pmc">PMC7283879</ArticleId><ArticleId IdType="pubmed">32464707</ArticleId></ArticleIdList></Reference><Reference><Citation>Esenwa C. et al.. COVID-19-associated carotid atherothrombosis and stroke. Am. J. Neuroradiol. 41, 1993–1995 (2020). doi: 10.3174/ajnr.A6752</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6752</ArticleId><ArticleId IdType="pmc">PMC7658853</ArticleId><ArticleId IdType="pubmed">32819896</ArticleId></ArticleIdList></Reference><Reference><Citation>Genchi A. et al.. Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients. Acta Neuropathol. Commun. 10, 14 (2022). doi: 10.1186/s40478-022-01313-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-022-01313-y</ArticleId><ArticleId IdType="pmc">PMC8805426</ArticleId><ArticleId IdType="pubmed">35105380</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q., Tong X., George M. G., Chang A. &amp; Merritt R. K. COVID-19 and Risk of Acute Ischemic Stroke Among Medicare Beneficiaries Aged 65 Years or Older. Neurology 98, e778 LP–e789 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8935393</ArticleId><ArticleId IdType="pubmed">35115387</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridman S., Lownie S. P. &amp; Mandzia J. Diagnosis and management of carotid free-floating thrombus: a systematic literature review. Int. J. Stroke 14, 247–256 (2019). doi: 10.1177/1747493019828554</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493019828554</ArticleId><ArticleId IdType="pubmed">30722756</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R.-J. et al.. Intraluminal thrombi in the cervico-cephalic arteries: clinical-imaging manifestations, treatment strategies, and outcome. Stroke 50, 357–364 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30595130</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>